about
Titanium particle-induced osteogenic inhibition and bone destruction are mediated by the GSK-3β/β-catenin signal pathway.Downregulation of miR-106b attenuates inflammatory responses and joint damage in collagen-induced arthritis.Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-κB pathway in rats.Tension force-induced bone formation in orthodontic tooth movement via modulation of the GSK-3β/β-catenin signaling pathway.Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.Melatonin Increases Bone Mass around the Prostheses of OVX Rats by Ameliorating Mitochondrial Oxidative Stress via the SIRT3/SOD2 Signaling PathwayCannabinoid Receptor 2 Agonist Prevents Local and Systemic Inflammatory Bone Destruction in Rheumatoid ArthritisTenocyte-derived exosomes induce the tenogenic differentiation of mesenchymal stem cells through TGF-βShikimic acid prevents cartilage matrix destruction in human chondrocytesAspirin-Mediated Attenuation of Intervertebral Disc Degeneration by Ameliorating Reactive Oxygen Species In Vivo and In VitroEffects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosisRelaxin inhibits patellar tendon healing in rats: a histological and biochemical evaluationAspirin inhibits osteoclast formation and wear-debris-induced bone destruction by suppressing mitogen-activated protein kinases
P50
Q41084327-BE37D0C6-7B36-4AD9-88C6-20B125D14AC2Q47731229-F1C8A5D2-DADF-4204-924C-9D40168C05D9Q48511601-E09BA479-CC18-421B-9D0E-77028290367FQ49971087-29FA40E4-185E-4293-83B4-71E6E2B797E8Q50228643-102B021D-8356-4D75-997F-587EBBD31EDEQ54116059-7380B467-1356-4940-B29F-74F2E38CFC43Q64056535-2759689A-A060-4B9D-9CB2-7B5148B0B342Q90216018-FB50CD32-8135-40F5-A0B6-EDCCB9F16674Q90835990-A9741382-EB99-4669-9901-6E1D05C917B3Q90873592-974303BF-AD88-4C53-96BB-9A558316F85FQ91531599-647426A7-98C7-4EE7-B215-E6D966B88669Q92208860-25C12538-C386-430C-B16E-859547B9C4D1Q92221421-58EF1100-B838-4F03-9409-2156A9636BAEQ93194239-DB816F29-EEB3-4087-9F6F-D03AA4D5ADF1
P50
description
researcher (ORCID 0000-0003-0947-4846)
@en
name
Yu Liu
@en
type
label
Yu Liu
@en
prefLabel
Yu Liu
@en
P31
P496
0000-0003-0947-4846